Occudo Quantitative Strategies’s BioVie BIVI Stock Holding History

Occudo Quantitative Strategies’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-223	Closed	-$96.1K	–	990
2023 Q2	$96.1K	Buy	+223	New	+$150K	0.01%	924

Other funds holding BIVI

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Occudo Quantitative Strategies's BIVI Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of BioVie (BIVI) in Q3 2023, closing a stake of 223 shares — an estimated $96.1K sold.

Occudo Quantitative Strategies first reported a position in BIVI in Q2 2023 and held it in 1 quarter. The position peaked at $96.1K in Q2 2023. 56 funds tracked by Wall St. Rank hold BIVI as of Q3 2023.

Occudo Quantitative Strategies reported no remaining BioVie position as of Q3 2023 after selling out during the quarter.
Occudo Quantitative Strategies sold 223 BioVie shares in Q3 2023, an estimated $96.1K.
Occudo Quantitative Strategies first reported a position in BioVie in Q2 2023 and held it in 1 quarter.
Occudo Quantitative Strategies's BioVie position peaked at $96.1K in Q2 2023.
56 funds tracked by Wall St. Rank held BioVie as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.